简介：新生血管性青光眼（neovascularglaucoma，NVG）是一种继发于其他眼部或全身性疾病的严重类型的青光眼，难以控制的眼压、视力的急剧下降和眼部疼痛症状是其特点。目前国内外对NVG的研究颇多，新的治疗方法不断被探索，然而手术仍是其目前最终的治疗方式，尤其抗血管内皮生长因子（vascularendothelialgrowthfactor，VEGF）药物与其它手术的联合治疗更是近年NVG治疗的热门话题。本文对NVG的治疗方面的不同方法和疗效进行综述。

简介：Choroidalneovascularization(CNV)isanuncommoncomplicationassociatedwithamacularhole.Inthiscasereportofararecondition,wepresentapathologicmyopiapatientwithaco-existentmacularholeandchoroidalneovascularmembrane.ThepatientwastreatedwithphotodynamictherapyforCNV,andthenvitreoussurgeryfortheretinaldetachmentandmacularhole.Attheendof4yearsfollow-up,hervisualacuitywasimprovedto0.1whilethemacularholeremainedopen.OpticalcoherencetomographyisausefulinspectionmethodofthediagnosisofCNVandmacularhole.

简介：目的研究可降解型VisiPlug泪道栓治疗准分子激光术后干眼的临床疗效。方法选取来我科就诊的23例（46只眼）拟行准分子激光手术且术前伴有轻到中度干眼患者，术后应用VisiPlug泪道栓进行泪道栓塞。分别于准分子激光术前、泪道栓塞术前、栓塞术后2周及3个月，针对于眼症状及泪道栓使用舒适度进行问卷调查，并行角膜荧光素染色、基础泪液分泌试验（SchirmerⅠtest，SⅠt）及泪膜破裂时间（break-uptime，BUT）检查，对疗效进行评价。结果准分子激光术后，患者干眼症状明显加重，SⅠt和BUT明显下降；泪道栓塞术后患者干眼症状明显减轻，SⅠt和BUT明显增加和延长，人工泪液使用频次下降；术后3个月所有患者角膜荧光素染色阴性。随访期间除1只眼栓塞术后1d泪道栓脱落外，无其他并发症发生。结论应用VisiPlug泪道栓可安全、有效地治疗准分子激光术后干眼，增加眼表泪液量，改善泪膜稳定性，缓解干眼症状，替代人工泪液的治疗。（中国眼耳鼻喉科杂志，2011，11：22-25）

简介：手法小切口白内障术（manualsmallincisioncataractsurgepy，MSICS）特别是在发展中国家已广泛应用于临床手术。本文旨在比较传统白内障囊外摘除术（extracapsularcataractextraction，ECCE）、MSICS以及超声乳化白内障吸除术治疗效果以及安全性（术中并发症以及术后并发症）。通过使用PubMed搜索引擎，我们收集了传统ECCE、MSICS以及超声乳化白内障吸除术的相关文献，以评价其安全性和治疗效果。同时，也参考了国内出版的相关文献。结果发现，与超声乳化白内障吸除术相比，传统ECCE以及MSICS也取得了很好的治疗效果，并且具有并发症少等优点。MSICS不需要依赖昂贵的仪器，并且具有手术快速、费用低廉以及技术门槛低等特点，特别适用于硬核白内障的治疗。虽然在白内障手术治疗过程中MSICS需要一定的技术和耐心，但它仍然是一种安全、有效、经济治疗手段，特别是在发展中国家可以替代超声乳化进行白内障的治疗。

简介：目的探讨自我管理项目在门诊青光眼患者中的应用及效果。方法将112例门诊青光眼患者随机分为56例对照组、56例干预组。对照组给予门诊常规药物治疗和常规健康教育指导;干预组在门诊常规药物治疗基础上,进行自我管理项目干预,比较两组病人的自我管理行为、自我效能水平和生活质量。结果干预后12周,干预组自我管理行为、自我效能水平和生活质量显著优于对照组（P〈0.05）。结论自我管理项目干预能提高青光眼患者自我管理行为、自我效能水平和生活质量。

简介：由中国科学评价中心,武汉大学图书馆及中国科教评价网联袂研发的《中国学术期刊评价研究报告》——RCCSE权威期刊,核心期刊排行榜与指南于2011年8月由科学出版社正式出版,这在国内外期刊评价史上具有新的里程碑意义。

简介：目的：评估单剂量枸橼酸西地那非片对早期年龄相关性黄斑变性（AMD）男性患者视功能的急性效应。方法：早期年龄相关性黄斑变性男40例，年龄58～86（平均71）岁，前瞻性随机接受安慰剂或者枸橼酸西地那非片（Viagra；PfizerInc，NewYork，NY）100mg，单次口服。受试者双眼在接受药物之前及之后9h内特定的时间间期进行视力、Amsler方格表及辨色力检查。结果：与安慰剂相比，服用枸橼酸西地那非片后视功能检查均未有明显改变。视力和辨色力检查在基线水平上未见有统计意义或临床相关的改变，Amsler方格表检查未见临床相关的改变。服用枸橼酸西地那非片与短暂的轻度至中度头痛和面红有关。结论：单次口服100mg枸橼酸西地那非片，在早期年龄相关性黄斑变性男性样本人群中，耐受性良好，未对视觉产生显著急性效应。

简介：AIM:Topresenttheoutcomeofmodifiedgridlaserphotocoagulation(GLP)indiffusediabeticmacularedema(DDME)ineyeswithoutextrafovealand/orvitreofovealtraction.METHODS:InclusioncriteriafortheretrospectivestudywereDDMEeyesofpatientswithtypeⅡdiabetesmellitusthathad≥4monthsoffollow-upfollowingGLP.Onlyoneeyeperpatientwasanalyzed.Using3-Dspectral-domainopticalcoherencetomography(3-DSDOCT),eyesthathadeitherextrafovealorvitreofovealtraction,orhadbeenpreviouslytreatedbyanintravitrealmedication(s)wereexcluded.TreatedDDMEeyesweredividedinto4groups:A)'Classic'DDMEthatinvolvedthecentralmacula;B)edemadidnotinvolvethemacularcenter;C)eyesassociatedwithcentralepiretinalmembrane(ERM);D)DDMEthatwasassociatedwithmacularcapillarydropout≥2disc-diameter(DD).RESULTS:GLPoutcomein35DDMEeyesafter4-24(mean,13.1±6.9)monthswasasfollows:GroupA)18eyeswith'classic'DDME.Followingoneor2(mean,1.2)GLPtreatments,best-correctedvisualacuity(BCVA)improvedby1-2Snellenlinesin44.4%(8/18)ofeyes,andworsenedby1linein11.1%(2/18).Centralmacularthickness(CMT)improvedby7%-49%(mean,26.6%)in77.8%(14/18)ofeyes.CausesofCMTworsening(n=4)werecommonlyexplainable,predominantly(n=3)associatedwithemergenceofextrafovealtraction,5-9monthspost-GLP.GroupB)GLP(s)inDDMEthatdidnotinvolvethemacularcenter(n=6)resultedinimprovedBCVAby1-2linesin2eyes.However,thecentralmaculabecameinvolvedintheedemaprocessaftertheGLPin3(50%)eyes,associatedwithanemergenceofextrafovealtractioninoneoftheseeyes4monthsfollowingtheGLP.GroupC)GLPfailedinall5eyesassociatedwithcentralERM.GroupD)GLPwasofpartialbenefitin2of6treatedeyeswithmacularcapillarydropout≥2DD.CONCLUSION:EyeswithDDMEthatinvolvedthemacularcenterwerefoundtoachievefavourableoutcomesafterGLP(s)duringmid-termfollow-up,unlesscomplicatedpre-GLPorpost-GLPbyvltreoretinalinterfaceabnormalities,oftenextrafovealtra

简介：AIM:Toinvestigatetheaccuracyofintraocularpressure(IOP)asmeasuredbyaReichertOcularResponseAnalyzer(ORA),aswellastherelationshipbetweencentralcornealthickness(CCT)andIOPasmeasuredbyORA,Goldmannapplanationtonometry(GAT),anddynamiccontourtonometry(DCT).·METHODS:Atotalof158healthyindividuals(296eyes)werechosenrandomlyformeasurementofIOP.AfterCCTwasmeasuredusingA-ultrasound(A-US),IOPwasmeasuredbyORA,GAT,andDCTdevicesinarandomizedorder.TheIOPvaluesacquiredusingeachofthethreetonometrieswerecompared,andtherelationshipbetweenCCTandIOPvalueswereanalyzedseparately.TwoIOPvalues,Goldmann-correlatedIOPvalue(IOPg)andcorneal-compensatedintraocularpressure(IOPcc),weregotusingORA.ThreegroupsweredefinedaccordingtoCCT:1)thincornea(CCT<520μm);2)normal-thicknesscornea(CCT:520-580μm);and3)thickcornea(CCT>580μm)groups.·RESULTS:Innormalsubjects,IOPmeasurementswere14.95±2.99mmHgwithORA(IOPg),15.21±2.77mmHgwithORA(IOPcc),15.22±2.77mmHgwithGAT,and15.49±2.56mmHgwithDCT.Meandifferenceswere0.01±2.29mmHgbetweenIOPccandGAT(P>0.05)and0.28±2.20mmHgbetweenIOPccandDC(P>0.05).TherewasagreatercorrelationbetweenIOPccandDCT(r=0.946,P=0.000)thanthatbetweenIOPccandGAT(r=0.845,P=0.000).DCThadasignificantcorrelationwithGAT(r=0.854,P=0.000).GATwasmoderatelycorrelatedwithCCT(r=0.296,P<0.001),whileIOPccshowedaweakbutsignificantcorrelationwithCCT(r=0.155,P=0.007).TherewasastrongnegativecorrelationbetweenCCTandthedifferencebetweenIOPccandGAT(r=-0.803,P=0.000),withevery10increaseinCCTresultinginanincreaseinthisdifferenceof0.35mmHg.Thethickcorneagroup(CCT>580μm)showedtheleastsignificantcorrelationbetweenIOPccandGAT(r=0.859,P=0.000);whilethethincorneagroup(CCT<520μm)hadthemostsignificantcorrelationbetweenIOPccandGAT(r=0.926,P=0.000).ThecorrelateddifferencesbetweenIOPccan

简介：AIM:Tofindouttheoutcomeoflaserphotocoagulationinclinicallysignificantmacularedema(CSME)byopticalcoherencetomography(OCT).·METHODS:Itwasaprospective,non-controlled,caseseriesstudyenrolling81eyesof64patientswithCSMEbetweenAugust2008andJanuary2010.AllpatientsreceivedmodifiedgridphotocoagulationwithfrequencydoubledNd:YAGlaser.Eachpatientwasevaluatedintermsofbest-correctedvisualacuity(BCVA)andregressionorprogressionofmaculopathyafterlasertherapyat1,3and6months.Spearman’scorrelationtestwasusedtoshowthecorrelationbetweenBCVAandtotalmacularvolume(TMV).Analysisofvariance(ANOVA)wasusedtocompareamonggroupsandindependentt-testwasusedtocompareineachgroup.·RESULTS:ThereishighcorrelationbetweenBCVAandTMV(P≤0.001).BCVAimprovedin50.6%,remainedstaticin39.5%anddeterioratedin9.9%patientsafter6monthoftreatment.TheBaselineTMV(meanandSD)were9.26±1.83,10.4±2.38,11.5±3.05,8.89±0.75and9.47±1.98mm3fordifferentOCTpatterns,ST(spongelikethickening),CMO(cystoidmacularedema),SFD(subfovealdetachment),VMIA(Vitreomacularinterfaceabnormality)andaverageTMVrespectively(P=0.04).After6monthsoflasertreatment,themeanTMVdecreasedfrom9.47±1.98mm3to8.77±1.31mm3(P=0.01).InSTtherewassignificantdecreaseinTMV,P=0.01,Furtherwithinthesegroupsat6months,theyweresignificantlydifferent,P=0.01.·CONCLUSION:OCTshowedthedifferentmorphologicalvariantofCSMEwhiletheresponseoftreatmentisdifferent.TMVdecreasedthemostandhenceshowedtheimprovementinvisionafter6monthsoflasertreatment.IntheeraofAntivascularendothelialgrowthfactors(VEGFs),efficacyoflaserseemstobeinshadowbutitisstillfirstlineoftreatmentindevelopingnationlikeNepalwhereantiVEGFsmaynotbeeasilyavailableandaffordable.